Intratumoral heterogeneity may be responsible for chemotherapy resistance in patients with small cell lung cancer

HOUSTON – Small cell lung cancer (SCLC) accounts for 14% of all lung cancers and is often rapidly resistant to chemotherapy, resulting in poor clinical outcomes. Treatment has changed little for decades, but a study at The University of Texas MD Anderson Cancer Center found that chemotherapy results in increased heterogeneity within the tumor, leading…

Details

Combination drug therapy for childhood brain tumors shows promise in laboratory models

In experiments with human cells and mice, researchers at the Johns Hopkins Kimmel Cancer Center report evidence that combining the experimental cancer medication TAK228 (also called sapanisertib) with an existing anti-cancer drug called trametinib may be more effective than either drug alone in decreasing the growth of pediatric low-grade gliomas. These cancers are the most…

Details

Coronavirus Live Updates: U.S. Cruise Ship Passengers Evacuated From Japan; Taiwan Reports First Death

Here’s what you need to know: Flights carrying American passengers from a cruise ship took off from Japan. ImageThe Daikoku Pier Cruise Terminal, where the Diamond Princess is docked in Yokohama, Japan, south of Tokyo.Credit…Franck Robichon/EPA, via Shutterstock American passengers evacuated a cruise ship that has been quarantined for more than a week in the…

Details